Evidence map›Paper›PMID 42026561›Full record

ArticleBMC oral health2026

Cytotoxicity of hexagonal boron nitride incorporated conventional and resin modified glass ionomer cements: in vitro study.

Songul Kilic, Sema Yazici Akbiyik, Demet Kacaroglu

Abstract read
In one paragraph

Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Songul KilicDepartment of Restorative Dentistry, Faculty of Dentistry, Lokman Hekim University, Ankara, Türkiye. songul.kilic@lokmanhekim.edu.tr.ORCID 0000-0002-9222-3679
Sema Yazici AkbiyikDepartment of Restorative Dentistry, Faculty of Dentistry, Lokman Hekim University, Ankara, Türkiye.ORCID 0000-0002-2134-7746
Demet KacarogluDepartment of Medical Biology, Faculty of Medicine, Lokman Hekim University, Ankara, Türkiye.ORCID 0000-0003-4920-0516

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncorporation of nanomaterials into cement has been proposed to enhance their physical performance; however, potential biological effects require careful evaluation. This study aimed to investigate cytotoxic profile of hexagonal boron nitride(hBN)-incorporated conventional glass ionomer cements(GIC) and resin-modified glass ionomer cements(RMGIC) using mouse fibroblasts(L929) and human umbilical vein endothelial cells(HUVECs).

methodsGIC and RMGIC specimens were modified with hBN nanoparticles at concentrations of 0.5 wt%, 1 wt%, and 1.5 wt% and unmodified materials were also included. A total of 56 disc-shaped specimens (5 mm×2 mm) were prepared (n = 7 per group). Extracts collected after 1-day and 7-day incubation periods were applied to L929 and HUVEC cells at dilutions of 1:2, 1:5, and 1:10. Cell viability was assessed after 48 and 96-hours using MTT assay. Data were analyzed using two-way ANOVA followed by Tukey’s post hoc test (α = 0.05).

resultsCell viability was significantly affected by material type, extract concentration, cell line, and exposure duration, with extracts obtained after 7 days showing significantly higher cytotoxicity compared to 1-day extracts in both L929 and HUVEC cells. In HUVEC cells, 7-day extracts resulted in lower viability than 1-day extracts, particularly at the 1:2 dilution and 96-hour exposure, where viability decreased to approximately 49% in the RMGIC-2 group. Under the same conditions, GIC groups showed relatively higher viability than RMGIC groups, although still below control levels. In contrast, L929 fibroblasts maintained generally higher viability, with most 96-hour values remaining above 70%, even with 7-day extracts. Higher dilutions (1:5 and 1:10) improved viability in both cell lines, especially at 48 h. Overall, RMGIC materials tended to reduce viability more than GIC, particularly in HUVEC cells under concentrated and prolonged exposure, while hBN incorporation did not induce a consistent or dose dependent increase in cytotoxicity.

conclusionsThe cytotoxic response of hBN incorporated cements depended on cell type, concentration, and exposure time. Within the tested conditions, hBN did not cause a consistent increase in cytotoxicity in either GIC or RMGIC. Importantly, the lack of a significant increase in cytotoxicity following hBN incorporation indicates that these modified cements maintain their biocompatibility, supporting their potential biological compatibility for clinical use.

Indexed as

Boron CompoundsGlass Ionomer CementsResin CementsAnimalsCell LineCell SurvivalFibroblastsHumansHuman Umbilical Vein Endothelial CellsMaterials TestingMiceBoron Compoundsboron nitrideGlass Ionomer CementsResin CementsCytotoxicityGlass ionomer cementHexagonal boron nitrideHUVECL929Resin-modified glass ionomer cement

Identifiers

PMID42026561
PMCPMC13273948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.